Literature DB >> 4066701

Protein kinase C in the human erythrocyte. Translocation to the plasma membrane and phosphorylation of bands 4.1 and 4.9 and other membrane proteins.

H C Palfrey, A Waseem.   

Abstract

Protein kinase C (PK-C) was demonstrated in human erythrocytes using the exogenous substrate histone H1. The enzyme was dependent on the simultaneous presence of micromolar Ca2+ and phosphatidylserine. The Ca2+ requirement was reduced in the presence of the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA). Activity was normally recovered in cytoplasmic extracts, but treatment of intact cells with TPA (EC50 = 40 nM) prior to lysis caused a rapid translocation of activity from the cytoplasm to the membrane. Following translocation, PK-C activity in the isolated membrane was independent of Ca2+ and phosphatidylserine and could not be removed by manipulating ionic strength. Ghosts from TPA-treated cells showed a marked increase in the phosphorylation of five proteins (termed PK-C-1-5) of Mr 120,000, 110,000, 80,000, 78,000, and 49,000. Addition of purified bovine brain PK-C to ghosts from untreated cells resulted in the phosphorylation of the same five proteins. PK-C-3/4 corresponded to Band 4.1 and PK-C-5 to Band 4.9. Both proteins were isolated from ghosts and shown to be substrates for PK-C in vitro. PK-C-1 and -2 appear to be minor peripheral membrane proteins as both were released from the membrane by alkaline solutions. Incubation of 32P-prelabeled erythrocytes with TPA (EC50 = 40 nM) also resulted in a dose-dependent phosphorylation of PK-C-1-5. These results suggest that PK-C may play an important role in erythrocyte membrane function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4066701

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  The spectrin-ankyrin-4.1-adducin membrane skeleton: adapting eukaryotic cells to the demands of animal life.

Authors:  Anthony J Baines
Journal:  Protoplasma       Date:  2010-07-29       Impact factor: 3.356

2.  Protein kinases A and C regulate receptor-mediated increases in cAMP in rabbit erythrocytes.

Authors:  Shaquria P Adderley; Meera Sridharan; Elizabeth A Bowles; Alan H Stephenson; Mary L Ellsworth; Randy S Sprague
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

Review 3.  Role of the phosphorylation of red blood cell membrane proteins.

Authors:  P Boivin
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

4.  Protein kinase C does not phosphorylate the externalized form of the transferrin receptor.

Authors:  M A Adam; R M Johnstone
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

5.  Inhibition of ATP release from erythrocytes: a role for EPACs and PKC.

Authors:  Shaquria P Adderley; Meera Sridharan; Elizabeth A Bowles; Alan H Stephenson; Randy S Sprague; Mary L Ellsworth
Journal:  Microcirculation       Date:  2011-02       Impact factor: 2.628

6.  Interaction of bilirubin with native and protein-depleted human erythrocyte membranes.

Authors:  Huma Rashid; Saad Tayyab
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

7.  Inhibitory action of polyamines on protein kinase C association to membranes.

Authors:  M Moruzzi; B Barbiroli; M G Monti; B Tadolini; G Hakim; G Mezzetti
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

8.  A 20 kDa erythrocyte membrane phosphoprotein.

Authors:  S Lee; E B Cunningham; N I Swislocki
Journal:  Mol Cell Biochem       Date:  1991-07-24       Impact factor: 3.396

9.  Calmodulin-binding domain of recombinant erythrocyte beta-adducin.

Authors:  D A Scaramuzzino; J S Morrow
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

10.  Effect of short-term hyperglycemia on protein kinase C alpha activation in human erythrocytes.

Authors:  Leonid Livshits; Ariel Srulevich; Itamar Raz; Avivit Cahn; Gregory Barshtein; Shaul Yedgar; Roy Eldor
Journal:  Rev Diabet Stud       Date:  2012-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.